Olivier Thomas

667 total citations
12 papers, 551 citations indexed

About

Olivier Thomas is a scholar working on Molecular Biology, Pharmaceutical Science and Infectious Diseases. According to data from OpenAlex, Olivier Thomas has authored 12 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Pharmaceutical Science and 2 papers in Infectious Diseases. Recurrent topics in Olivier Thomas's work include Advancements in Transdermal Drug Delivery (2 papers), Mesenchymal stem cell research (2 papers) and RNA Interference and Gene Delivery (2 papers). Olivier Thomas is often cited by papers focused on Advancements in Transdermal Drug Delivery (2 papers), Mesenchymal stem cell research (2 papers) and RNA Interference and Gene Delivery (2 papers). Olivier Thomas collaborates with scholars based in France, Egypt and United States. Olivier Thomas's co-authors include Vincent Bessonneau, Frédéric Lagarce, Claudia N. Montero‐Menei, Jean‐Pierre Benoît, Marie‐Claire Venier‐Julienne, Gaëtan J.-R. Delcroix, Paul C. Schiller, Laurence Sindji, Elisa Garbayo and Claire Vanpouille‐Box and has published in prestigious journals such as PLoS ONE, Biomaterials and International Journal of Pharmaceutics.

In The Last Decade

Olivier Thomas

12 papers receiving 542 citations

Peers

Countries citing papers authored by Olivier Thomas

Since Specialization

Citations

This map shows the geographic impact of Olivier Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Thomas more than expected).

Fields of papers citing papers by Olivier Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Thomas. The network helps show where Olivier Thomas may publish in the future.

Co-authorship network of co-authors of Olivier Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Thomas. A scholar is included among the top collaborators of Olivier Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Thomas. Olivier Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro 2020 ·Neurochemical Research ·Catherine Fressinaud, Olivier Thomas, Anita Umerska, Patrick Saulnier	6
2	Identification of aqueous reservoirs in poly(alkylcyanoacrylate) nanoparticles 2020 ·Colloid & Polymer Science ·Olivier Thomas, Laurent Lemaire, Jean‐Pierre Benoît, Patrick Saulnier	2
3	Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide 2013 ·European Journal of Pharmaceutical Sciences ·(unknown), Olivier Thomas, Nolwenn Lautram, Anne Clavreul, J. Hureaux, T. Urban, Jean‐Pierre Benoît, Frédéric Lagarce	43
4	VOC Contamination in Hospital, from Stationary Sampling of a Large Panel of Compounds, in View of Healthcare Workers and Patients Exposure Assessment 2013 ·PLoS ONE ·Vincent Bessonneau, (unknown), (unknown), (unknown), Sylvie Buffet‐Bataillon, Jean‐Pierre Gangneux, Olivier Thomas	84
5	Lipid Nanocapsules: A Nanocarrier Suitable for Scale-Up Process 2013 ·Journal of Drug Delivery Science and Technology ·Olivier Thomas, Frédéric Lagarce	38
6	Assessment of Exposure to Alcohol Vapor from Alcohol-Based Hand Rubs 2012 ·International Journal of Environmental Research and Public Health ·Vincent Bessonneau, Olivier Thomas	39
7	Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study 2011 ·International Journal of Nanomedicine ·Frédéric Lagarce, Alyaa A. Ramadan, (unknown), (unknown), Olivier Thomas, Laurent Macchi, Patrick Saulnier, Jean‐Pierre Benoît	43
8	The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats 2010 ·Biomaterials ·Gaëtan J.-R. Delcroix, Elisa Garbayo, Laurence Sindji, Olivier Thomas, Claire Vanpouille‐Box, Paul C. Schiller, Claudia N. Montero‐Menei	95
9	The role of pharmacologically active microcarriers releasing TGF-β3 in cartilage formation in vivo by mesenchymal stem cells 2010 ·Biomaterials ·Carine Bouffi, Olivier Thomas, Claire Bony, (unknown), Marie‐Claire Venier‐Julienne, Christian Jørgensen, Claudia N. Montero‐Menei, Danièle Noël	91
10	Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique 2010 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), Olivier Thomas, Xavier Garric, Jean Coudane, Stéphane Marchal, Igor Chourpa, Jean‐Pierre Benoît, Claudia N. Montero‐Menei, Marie‐Claire Venier‐Julienne	59
11	Can Intensive Use of Alcohol-Based Hand Rubs Lead to Passive Alcoholization? 2010 ·International Journal of Environmental Research and Public Health ·Vincent Bessonneau, Michel Clément, Olivier Thomas	25
12	Development and characterization of interleukin-18-loaded biodegradable microspheres 2006 ·International Journal of Pharmaceutics ·Frédéric Lagarce, Emmanuel Garcion, N. Faisant, Olivier Thomas, Parijat Kanaujia, Philippe Meneï, Jean‐Pierre Benoît	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact